Albizua E, Gallardo M, Barrio S, Rapado I, Jimenez A, Ayala R, Rueda D, Sanchez-Espiridion B, Puigdecanet E, Espinet B, Florensa L, Besses C, Martinez-Lopez J. Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia.
Ann. Hematol.  2011; 90: 939-946  F.I.: 2,688

Beltran E, Fresquet V, Martinez-Useros J, Richter-Larrea JA, Sagardoy A, Sesma I, Almada LL, Montes-Moreno S, Siebert R, Gesk S, Calasanz MJ, Malumbres R, Rieger M, Prosper F, Lossos IS, Piris MA, Fernandez-Zapico ME, Martinez-Climent JA. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.
Proc. Natl. Acad. Sci. U. S. A.  2011; 108: 12461-12466  F.I.: 9,771

Bueno MJ, Gómez de Cedrón M, Gómez-López G, Pérez de Castro I, Di Lisio L, Montes-Moreno S, Martínez N, Guerrero M, Sánchez-Martínez R, Santos J, Pisano DG, Piris MA, Fernández-Piqueras J, Malumbres M. Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway.
Blood  2011; 117: 6255-6266  F.I.: 10,558

Camacho FI, Bellas C, Corbacho C, Caleo A, Arranz-Sáez R, Cannata J, Menárguez J, Sánchez-Verde L, González-Camacho L, Pérez-Martín ME, Martínez-González MA, Alvaro T, Mollejo M, Ruíz-Marcellán C, Montalbán C, Piris MA. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells.
Mod. Pathol.  2011; 24: 698-707  F.I.: 4,176

Cerliani JP, Guillardoy T, Giulianelli S, Vaque JP, Gutkind JS, Vanzulli SI, Martins R, Zeitlin E, Lamb CA, Lanari C. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
Cancer Res.  2011; 71: 3720-3731  F.I.: 8,234

Chigrinova E, Mian M, Shen Y, Greiner TC, Chan WC, Vose JM, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Tucci A, Facchetti F, Lazure T, Lambotte O, Montes-Moreno S, Piris MA, Zucca E, Kwee I, Bertoni F. Integrated profiling of diffuse large B-cell lymphoma with 7q gain.
Br. J. Haematol.  2011; 153: 499-503  F.I.: 4,942

de la Hera Magallanes AI, Montes-Moreno S, Hernández SG, Hernández-León CN, Lopez M, Pajares R, Pinilla SM, Piris MA. Early phase of Epstein-Barr virus (EBV)-positive diffuse large B cell lymphoma of the elderly mimicking EBV-positive reactive follicular hyperplasia.
Histopathology  2011; 59: 571-575  F.I.: 3,569

Gómez-Abad C, Pisonero H, Blanco-Aparicio C, Roncador G, González-Menchén A, Martinez-Climent JA, Mata E, Rodríguez ME, Muñoz-González G, Sánchez-Beato M, Leal JF, Bischoff JR, Piris MA. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.
Blood  2011; 118: 5517-5527  F.I.: 10,558

González-López MA, González-Vela MC, Salas-Venero CA, Conde R, Val-Bernal JF. Cutaneous infection caused by Nocardiopsis dassonvillei presenting with sporotrichoid spread.
J. Am. Acad. Dermatol.  2011; 65: 0-0  F.I.: 4,274

González-López MA, González-Vela MC, Yáñez S, Fernández-Llaca H, Val-Bernal JF. Psoriasiform skin eruption associated with sorafenib therapy.
Indian J. Dermatol. Venereol. Leprol.  2011; 77: 614-615  F.I.: 0,932

González-Rodilla I, Verna V, Muñoz AB, Estévez J, Boix M, Schneider J. Expression of the apoptosis-related genes Bcl-2 and p53 in clinical samples from endometrial carcinoma patients.
Anticancer Res.  2011; 31: 4191-4193  F.I.: 1,656

Greaves WO, Kim JE, Singh RR, Drakos E, Kunkalla K, Sánchez-Espiridión B, Garcia JF, Medeiros LJ, Vega F. Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Hum. Pathol.  2011; 42: 1643-1652  F.I.: 2,998

Kanellis G, Garcia-Alonso L, Camacho FI, Garcia JF, Mollejo M, Montes-Moreno S, Garcia-Vela JA, Piris MA. Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case.
Leukemia  2011; 52: 1589-1592  F.I.: 8,966

Martín-Sánchez E, Sánchez-Beato M, Rodríguez ME, Sánchez-Espiridión B, Gómez-Abad C, Bischoff JR, Piris MA, García-Orad A, García JF. HDAC inhibitors induce cell cycle arrest, activate the apoptotic extrinsic pathway and synergize with a novel PIM inhibitor in Hodgkin lymphoma-derived cell lines.
Br. J. Haematol.  2011; 152: 352-356  F.I.: 4,942

Maruyama T, Li J, Vaque JP, Konkel JE, Wang W, Zhang B, Zhang P, Zamarron BF, Yu D, Wu Y, Zhuang Y, Gutkind JS, Chen W. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3.
Nat. Immunol.  2011; 12: 86-95  F.I.: 25,668

Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Díaz Uriarte R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C, Xu-Monette Z, Young KH, Piris MA. miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.
Blood  2011; 118: 1034-1040  F.I.: 10,558

Montes-Moreno S, Montalbán C, Piris MA. Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge.
Leukemia  2011; : 0-0  F.I.: 8,966

Piris MA, Arribas A, Mollejo M. Marginal zone lymphoma.
Semin. Diagn. Pathol.  2011; 28: 135-145  F.I.: 1,647

Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, Villamor N, Escaramis G, Jares P, Beà S, González-Díaz M, Bassaganyas L, Baumann T, Juan M, López-Guerra M, Colomer D, Tubío JM, Navarro A, Tornador C, Aymerich M, Rozman M, Hernández JM, Puente DA, Freije JM, Velasco G, Gutiérrez-Fernández A, Costa D, Carrió A, Guijarro S, Enjuanes A, Hernández L, Yagüe J, Nicolás P, Romeo-Casabona CM, Himmelbauer H, Castillo E, Dohm JC, de Sanjosé S, Piris MA, de Alava E, San Miguel J, Royo R, Gelpí JL, Torrents D, Orozco M, Pisano DG, Valencia A, Guigó R, Bayés M, Heath S, Gut M, Klatt P, Marshall J, Raine K, Stebbings LA, Futreal PA, Stratton MR, Campbell PJ, Gut I, López-Guillermo A, Estivill X, Montserrat E, López-Otín C, Campo E. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
Nature  2011; 475: 101-105  F.I.: 36,104

Ramos-Medina R, Montes-Moreno S, Maestre L, Cañamero M, Rodriguez-Pinilla M, Lázaro A, Roncador G. Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues.
Immunol. Lett.  2011; 134: 150-156  F.I.: 2,511

Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, Rancoita PM, De Campos CP, Forconi F, Gascoyne RD, Facchetti F, Ponzoni M, Govi S, Ferreri AJ, Mollejo M, Piris MA, Baldini L, Soulier J, Thieblemont C, Canzonieri V, Gattei V, Marasca R, Franceschetti S, Gaidano G, Tucci A, Uccella S, Tibiletti MG, Dirnhofer S, Tripodo C, Doglioni C, Dalla Favera R, Cavalli F, Zucca E, Kwee I, Bertoni F. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
Blood  2011; 117: 1595-1604  F.I.: 10,558

Robledo C, García JL, Benito R, Flores T, Mollejo M, Martínez-Climent JÁ, García E, Gutiérrez NC, Piris MA, Hernández JM. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.
PLoS One  2011; 6: 0-0  F.I.: 4,411

Rodríguez-Pinilla SM, Barrionuevo C, García J, Angeles MD, Pajares R, Casavilca S, Montes J, Martínez A, Montes-Moreno S, Sánchez L, Piris MA. Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases.
Histopathology  2011; 59: 1183-1193  F.I.: 3,569

Testoni M, Kwee I, Greiner TC, Montes-Moreno S, Vose J, Chan WC, Chiappella A, Baldini L, Ferreri AJ, Gaidano G, Mian M, Zucca E, Bertoni F. Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Br. J. Haematol.  2011; 155: 274-277  F.I.: 4,942